Lance Alstodt, President, CEO, COB, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 2,200 shares at $1.70 ($4K) on 2023-09-15, disclosed to the SEC on 2023-09-18.
Open-market purchase of $4k BRTX by President, CEO, COB, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BRTX | BUY | 2023-07-25 | $10K | — | Filing → |
| BRTX | BUY | 2023-02-02 | $1K | — | Filing → |
| BRTX | BUY | 2023-01-30 | $602 | — | Filing → |